• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Bracco Imaging explores using microbubbles to deliver personalized gene therapy

January 23, 2018 By Sarah Faulkner

BraccoBracco Imaging has launched a new effort at its Switzerland-based R&D center to evaluate gas-filled microbubbles, usually used for diagnostic imaging, as a delivery vehicle for personalized gene therapies to treat chronic dysfunctional diseases linked to lipid metabolism.

The research project is part of a deal that Bracco signed with startup SonoGene, which is developing platforms for the therapeutic delivery of genes and drugs using ultrasound-triggered microbubble delivery systems.

“Today’s kick-off of new research activities provides an additional opportunity to exploit the microbubble platform and create an innovative therapeutic approach to addressing unmet medical needs,” Thierry Bettinger, director of the research department at Bracco, said in prepared remarks.

“We consider the personalized gene therapy under evaluation as an opportunity to expand the use of the microbubble platform. We are looking for a large number of biomedical applications, and are confident that our technology can be used to address a wide range of healthcare challenges.”

“SonoGene’s early animal studies successfully showed that tiny microbubbles can deliver genes to a targeted organ system and produce a desired therapeutic effect,” Dr. Steven Feinstein, co-president of the International Contrast Ultrasound Society, added. “SonoGene’s gene therapy can ultimately harness the body’s own biological mechanisms to provide a natural form of therapy.”

“Our investments to exploit innovative approaches of the microbubble platform reinforce our commitment and leadership in ultrasound, while fostering future applications of this technique beyond diagnostic imaging,” chief strategy officer Micol Fornaroli said.

“SonoGene is excited to collaborate with Bracco Imaging and leverage our unique and extensive expertise in the development of microbubble-based gene and drug delivery systems to save lives and improve patient care,” SonoGene CEO Eric Coles said. 

Want to stay on top of DDBN content? Sign up for our e-mail newsletter for a weekly dose of drug-device news.

Filed Under: Diagnostics, Drug-Device Combinations, Featured, Imaging, Pharmaceuticals, Research & Development Tagged With: Bracco Diagnostics

IN CASE YOU MISSED IT

  • FDA approves first targeted infusion therapy for HER2-low breast cancer
  • Abbott, WeightWatchers partner on diabetes care
  • Insulet up on Q2 sales beat, raised full-year guidance
  • Aptar acquires Orbital dry powder inhaler license
  • Tandem sinks on Q2 misses, slashed sales guidance

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS